NovelCath
Manufacturing · Minnesota, United States · 201-500 Employees
View Company Info for Free
Overview
Headquarters
8609 Xylon Ct Ste 101A, Minneapolis, Min...Phone Number
(763) 494-5551Website
www.novelcath.comRevenue
$18.5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
2
1
1
1
1
1
About NovelCath
NovelCath is a contract manufacturer based in Minneapolis, MN, specializing in the design, development, and manufacturing of minimally invasive interventional delivery systems for applications in Structural Heart, Electrophysiology, and Neurovascular fields. The company, part of Cirtec Medical, integrates Cardea Catheter Innovations to enhance its capabilities in producing complex catheter devices. With a team of industry veterans boasting over 70 years of experience, NovelCath focuses on R&D and prototyping to support early-stage development programs. Their vertically integrated facility includes advanced technologies for catheter assembly and Nitinol processing.Explore more
NovelCath Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is NovelCath your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Product Launch: Get notified when NovelCath launches new products
Check out if NovelCath is spiking on competitors!
Click to see if NovelCath had a recent Job posting/layoffs
Funding: Get notified immidiatlly once NovelCath has new funding data
Earning: See what the market has to say on NovelCath recently announced quarterly report
Congratulate Masked Content for being promoted to Masked Content at NovelCath
Website visits: Recent activity has been detected on your website
NovelCath, which may be a good buyer, showed buying intent in Masked Content Topic
Check if NovelCath has recently received funding, and reach out quickly before it becomes old news!
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 3 more new buyers
Compare Similar Companies to NovelCath
Compare insights from companies similar to NovelCath, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
NovelCath is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
NovelCath is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about NovelCath.
NovelCath financials insights
Gather financial insights about NovelCath, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2020
Debt
$150K
NovelCath Tech Stack
A closer look at the technologies used by NovelCath
Most Recent Scoops
Mergers & Acquisitions (M&A)
Funding
NovelCath has received an SBA PPP loan for $150,000-350,000 from Wells Fargo Bank.
Funding
NovelCath has received an SBA PPP loan for $150,000-350,000 from Wells Fargo Bank, National Association.
Funding
NovelCath News & Media
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding NovelCath
Sign Up For FreeTo access detailed company insights
NovelCath is a contract manufacturer based in Minneapolis, MN, specializing in the design, development, and manufacturing of minimally invasive interventional delivery systems for applications in Structural Heart, Electrophysiology, and Neurovascular fields. The company, part of Cirtec Medical, integrates Cardea Catheter Innovations to enhance its... Read More
